Skip to main content
Equibles
CPIX logo

CPIX · Cumberland Pharmaceuticals Inc · Webcasts, Transcripts & Audio

Track CPIX — free

Use CPIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CPIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.07 +0.09 (+1.29%)
Rebalance outlook locked
Market Cap
$106.90M
Shares
14.98M
Volume · Oct 9 26.3K Avg daily vol (3M) 87.14K

Cumberland Pharmaceuticals Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Cumberland Pharmaceuticals Inc (CPIX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲41.4% $11.41M −$408,639 '22 Q3 22-11-08 ▲9.7% $9.12M −$2.44M '22 Q4 23-03-07 ▼17.5% $9.22M $192,184 '23 Q1 23-05-09 ▲5.7% $10.89M $872,200 '23 Q2 23-08-08 ▼11.6% $10.09M −$1.05M '23 Q3 23-11-07 ▲2.5% $9.35M −$6.29M '23 Q4 24-03-05 ▼7.9% $8.50M −$1.95M '24 Q1 24-05-07 ▼9.6% $9.85M −$1.09M '24 Q2 24-08-06 ▼9.9% $9.09M −$1.54M '24 Q3 24-11-07 ▲11.6% $10.44M −$1.90M '24 Q4 25-03-04 ▲37.8% $11.71M $1.26M '25 Q1 25-05-06 ▼96.1% $380,797 −$740,740 '25 Q2 25-08-05 ▼8.7% $8.29M −$1.94M '25 Q3 25-11-04 ▲31.1% $13.68M −$1.41M '25 Q4 26-03-03 ▼22% $9.13M −$3.29M '26 Q1 26-05-05 LATEST ▼56.3% $166,458 −$4.28M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
Cumberland Pharmaceuticals Inc (CPIX) Q2 2026 Earnings Call Transcript
Confident tone Strategic Transaction with Apotex FDA Regulatory Engagement and Designations Duchenne Muscular Dystrophy Program
Revenue
$166,458
▼ 56.3% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Cumberland Pharmaceuticals Inc (CPIX) Q1 2026 Earnings Call Transcript
Confident tone Caldolor label expansion Strategic transaction with Apotex Talicia commercialization
Revenue
$9.13M
▼ 22% YoY
Diluted EPS
$-0.22
▼ 375% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Transcript
Positive tone Revenue growth and product portfolio Clinical pipeline and DMD program Operating expenses and net loss
Revenue
$13.68M
▲ 31.1% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Cumberland Pharmaceuticals Inc (CPIX) Q3 2025 Earnings Call Transcript
Confident tone Portfolio brand performance and sales organization International expansion Ifetroban clinical pipeline
Revenue
$8.29M
▼ 8.7% YoY
Diluted EPS
$-0.13
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Cumberland Pharmaceuticals Inc (CPIX) Q2 2025 Earnings Call Transcript
Confident tone Vibativ antibiotic franchise Ifetroban clinical pipeline Marketed brand portfolio performance
Revenue
$380,797
▼ 96.1% YoY
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Transcript
Confident tone Brand portfolio performance DMD clinical program (ifetroban) Vibativ antibiotic
Revenue
$11.71M
▲ 37.8% YoY
Diluted EPS
$0.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Transcript
Confident tone Ifetroban / Duchenne Muscular Dystrophy clinical program Vibativ antibiotic growth and international expansion Caldolor product evidence and FDA updates
Revenue
$10.44M
▲ 11.6% YoY
Diluted EPS
$-0.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cumberland Pharmaceuticals Inc (CPIX) Q3 2024 Earnings Call Transcript
Positive tone Brand portfolio performance International expansion and partnerships Medicaid coverage expansion for Kristalose
Revenue
$9.09M
▼ 9.9% YoY
Diluted EPS
$-0.11
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Cumberland Pharmaceuticals Inc (CPIX) Q2 2024 Earnings Call Transcript
Positive tone Vibativ product and pipeline Kristalose commercial updates Caldolor and NOPAIN Act
Revenue
$9.85M
▼ 9.6% YoY
Diluted EPS
$-0.08
▼ 233.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Cumberland Pharmaceuticals Inc (CPIX) Q1 2024 Earnings Call Transcript
Positive tone Caldolor growth and NOPAIN Act Vibativ brand updates and international expansion Kristalose Medicaid coverage
Revenue
$8.50M
▼ 7.9% YoY
Diluted EPS
$-0.14
▼ 1500% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Cumberland Pharmaceuticals Inc (CPIX) Q4 2023 Earnings Call Transcript
Positive tone Brand performance and revenue Caldolor pediatric labeling and No Pain Act International expansion of Vibativ
Revenue
$9.35M
▲ 2.5% YoY
Diluted EPS
$-0.44
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Cumberland Pharmaceuticals Inc (CPIX) Q3 2023 Earnings Call Transcript
Revenue
$10.09M
▼ 11.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Cumberland Pharmaceuticals Inc (CPIX) Q2 2023 Earnings Call Transcript
Revenue
$10.89M
▲ 5.7% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Cumberland Pharmaceuticals Inc (CPIX) Q1 2023 Earnings Call Transcript
Revenue
$9.22M
▼ 17.5% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Cumberland Pharmaceuticals Inc (CPIX) Q4 2022 Earnings Call Transcript
Revenue
$9.12M
▲ 9.7% YoY
Diluted EPS
$-0.17
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Cumberland Pharmaceuticals Inc (CPIX) Q3 2022 Earnings Call Transcript
Revenue
$11.41M
▲ 41.4% YoY
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Cumberland Pharmaceuticals Inc (CPIX) Q2 2022 Earnings Call Transcript
Revenue
$10.30M
▲ 13.7% YoY
Diluted EPS
$-0.09
▼ 212.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Cumberland Pharmaceuticals Inc (CPIX) Q1 2022 Earnings Call Transcript
Revenue
$11.18M
▲ 6.1% YoY
Diluted EPS
$-0.09
▼ 1000% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Cumberland Pharmaceuticals Inc (CPIX) Q4 2021 Earnings Call Transcript
Revenue
$8.32M
▼ 18.9% YoY
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Cumberland Pharmaceuticals Inc (CPIX) Q3 2021 Earnings Call Transcript
Revenue
$8.07M
▼ 12.7% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Cumberland Pharmaceuticals Inc (CPIX) Q2 2021 Earnings Call Transcript
Revenue
$9.06M
▼ 5.7% YoY
Diluted EPS
$0.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Cumberland Pharmaceuticals Inc (CPIX) Q1 2021 Earnings Call Transcript
Revenue
$10.54M
▲ 26.5% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-09
Cumberland Pharmaceuticals Inc (CPIX) Q4 2020 Earnings Call Transcript
Revenue
$10.26M
▲ 10.3% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Cumberland Pharmaceuticals Inc (CPIX) Q3 2020 Earnings Call Transcript
Revenue
$9.25M
▲ 33.4% YoY
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-11
Cumberland Pharmaceuticals Inc (CPIX) Q2 2020 Earnings Call Transcript
Revenue
$9.60M
▲ 1.9% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-20
Cumberland Pharmaceuticals Inc (CPIX) Q1 2020 Earnings Call Transcript
Revenue
$8.33M
▼ 4.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-18
Cumberland Pharmaceuticals Inc (CPIX) Q4 2019 Earnings Call
Revenue
$9.31M
▼ 31.1% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1087294 CUSIP 230770109 13F (30d) 1 filings 1 filers Visit website Investor relations